Exploring the Effect of Nice Guidelines on Prescribing for Childhood Atopic Eczema in Primary Care with An Interrupted Time Series
Introduction Atopic eczema (AE) is a chronic inflammatory skin condition affecting 20-32% of UK children, typically diagnosed and treated in primary care. National Institute of Health and Clinical Excellence (NICE, 2007) guidelines recommend all children presenting with AE in primary care are prescr...
Asıl Yazarlar: | LIW Schreuders, SJ Ersser, C Thompson |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Swansea University
2020-12-01
|
Seri Bilgileri: | International Journal of Population Data Science |
Online Erişim: | https://ijpds.org/article/view/1613 |
Benzer Materyaller
-
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
Yazar:: Curtis, HJ, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis”
Yazar:: Curtis, H, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Management of Atopic Eczema in primary care
Yazar:: Ainol Haniza Kherul Anuwar, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01) -
Parents' and carers' views about emollients for childhood eczema: qualitative interview study.
Yazar:: Santer, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Childhood atopic eczema: children’s
Quality of life and family impact
Yazar:: Ghani, Ahmad Abir Ab
Baskı/Yayın Bilgisi: (2012)